Free Trial
$100 Off. Every Year. Lock In MarketBeat All Access at $149
Claim the Rate Lock
Claim MarketBeat All Access Sale Promotion
NYSE:HY

Hyster-Yale Q3 2026 Earnings Date & Estimates

Hyster-Yale logo
$29.71 +0.77 (+2.65%)
Closing price 10/21/2026 03:59 PM Eastern
Extended Trading
$29.76 +0.05 (+0.18%)
As of 10/21/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Hyster-Yale is estimated to report Q3 2026 earnings on Tuesday, November 3, 2026, after market closes. The conference call is scheduled for November 4, 2026 at 11:00 AM ET.

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
After Market Closes
Conference Call Date
Conference Call
11:00 AM ET

What Analysts Expect from Hyster-Yale in Q3 2026

Hyster-Yale is expected to post earnings of -$0.59 per share on revenue of $926.45 million. In the same quarter a year earlier Hyster-Yale reported -$0.09 per share on revenue of $979.10 million. Hyster-Yale last reported on August 4, 2026, posting -$1.64 per share and beating the -$2.20 consensus estimate. Hyster-Yale has beaten the consensus EPS estimate in 4 of its last 8 quarters.

Consensus Estimates

Consensus EPS
-$0.59
Expected Revenue
$926.45 million
Prior-Year EPS
-$0.09
Prior-Year Revenue
$979.10 million
Expected Revenue Growth
-5.4%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
-$1.64 (Beat by +$0.56)
Last Quarter Revenue
$812.90 million
EPS Beat Rate
4 of last 8 quarters

Hyster-Yale Q3 2026 Earnings FAQ

Hyster-Yale (NYSE:HY) is estimated to report Q3 2026 earnings on Tuesday, November 3, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

Hyster-Yale's Q3 2026 earnings conference call is scheduled for Wednesday, November 4, 2026 at 11:00 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Hyster-Yale to post earnings of -$0.59 per share for Q3 2026.

The consensus revenue estimate for Hyster-Yale is $926.45 million for Q3 2026.

Hyster-Yale Earnings Headlines

Last call for your free 0DTE report
The 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, protect it. This report normally sells for 29.97, but it's available as a free download for a limited time.tc pixel
Hyster-Yale Appoints Matthew Cornell as CFO
See More Hyster-Yale Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Hyster-Yale? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Hyster-Yale and other key companies, straight to your email.

About Hyster-Yale

Hyster-Yale (NYSE:HY) Materials Handling, Inc. (NYSE: HY) designs, engineers, manufactures, sells and services materials-handling equipment and related solutions. Its principal products include lift trucks, warehouse equipment and replacement parts used to move, store and manage materials in industrial, distribution, manufacturing and logistics operations.

The company markets its lift trucks and materials-handling products primarily under the Hyster and Yale brand names. Its portfolio includes electric, internal-combustion and fuel-cell-powered lift trucks, as well as warehouse equipment and other specialized solutions. Through its Bolzoni business, Hyster-Yale also provides lift-truck attachments, forks and related equipment, while its Nuvera subsidiary develops hydrogen fuel-cell engines and power systems.

Hyster-Yale serves customers through a global network of dealers, distributors and direct sales operations across North America, Europe, Asia-Pacific, Latin America and other international markets. The company was established as an independent publicly traded business in 2012 following its separation from NACCO Industries. Rajiv Prasad serves as president and chief executive officer.

View Hyster-Yale Profile